These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway. Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961 [TBL] [Abstract][Full Text] [Related]
31. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832 [TBL] [Abstract][Full Text] [Related]
32. Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis. Ma H; Yu S; Liu X; Zhang Y; Fakadej T; Liu Z; Yin C; Shen W; Locasale JW; Taylor JM; Qian L; Liu J Circulation; 2019 Apr; 139(14):1725-1740. PubMed ID: 30636447 [TBL] [Abstract][Full Text] [Related]
33. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763 [TBL] [Abstract][Full Text] [Related]
34. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure. Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107 [TBL] [Abstract][Full Text] [Related]
35. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress. Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997 [TBL] [Abstract][Full Text] [Related]
36. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy. Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292 [TBL] [Abstract][Full Text] [Related]
37. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis. Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms. Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648 [TBL] [Abstract][Full Text] [Related]
39. Antioxidant N-acetylcysteine inhibits maladaptive myocyte autophagy in pressure overload induced cardiac remodeling in rats. Li B; Sun Y; Wang JP; Chi RF; Wang K; Yang ZJ; Qin FZ; Fan B Eur J Pharmacol; 2018 Nov; 839():47-56. PubMed ID: 30194941 [TBL] [Abstract][Full Text] [Related]
40. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure. Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]